For gout pain that does not respond to conventional therapies, patients’ only remaining option is a drug from Amgen. But this biologic medicine introduces the same problem facing every therapeutic ...

Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire Arthrosi Therapeutics, a startup with a gout drug candidate in Phase 3 ...

(Reuters) -Crystalys Therapeutics said on Tuesday it has emerged from stealth mode with a funding round of $205 million to help finance global late-stage trials of its lead drug as a treatment for ...

A drug used to treat gout could reduce the risk of a heart attack or stroke, according to a new study. Researchers found colchicine - an inexpensive drug used to treat the painful type of arthritis - ...

New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

The MarketWatch News Department was not involved in the creation of this content. -- Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients ...

October 2, 2012 — New gout guidelines from the American College of Rheumatology are meant to improve gout management by providing clinicians with clear, readily implemented guidance on urate-lowering ...

When you think of arthritis, achy, warm, swollen joints probably come to mind. These are indeed some of the most common symptoms of arthritis. But did you know there are actually over 100 different ...

Please provide your email address to receive an email when new articles are posted on . Prophylaxis use and less-intense urate lowering therapy were associated with fewer gout flares. More studies are ...

Management of a patient allergic to allopurinol can be considered a therapeutic challenge. This article highlights the diversity of medications that can be used to manage hyperuricemia during this ...

Weight-loss injections such as Ozempic and Wegovy are helping millions lose weight quickly. But could rapid weight loss affect bone strength and increase gout risk?

Savient Pharmaceuticals of East Brunswick said its gout drug, Puricase (pegloticase), reached its main goal in late-stage trials, achieving statistically significant positive results in the late-stage ...